Kabra Drugs Board Meeting on Pharma, Defense AI Expansion

Kabra Drugs Ltd intimated a board meeting scheduled for May 6, 2026, pursuant to SEBI LODR Regulation 29.
The board will discuss pharmaceutical manufacturing and marketing expansion through strategic channel partners.
It will also evaluate opportunities in defense manufacturing using Artificial Intelligence (AI) technologies.